Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Multiple Sclerosis

Free Subscription Articles published in Neurology Retrieve available abstracts of 237 articles: HTML format Text format

Single Articles

January 2012
1. FOX RJ , Rudick RA
   Risk stratification and patient counseling for natalizumab in multiple sclerosis.
   Neurology. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. LUNEMANN JD
   Epstein-Barr virus in multiple sclerosis: A continuing conundrum.
   Neurology. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. WIEBENGA OT , Hulst HE, Kooi EJ, Killestein J, et al
   Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.
   Neurology. 2011;77:1998-2000.
   PubMed     Text format     Related articles   
   
   
   
   
4. HEILMAN KM , Williamson JB
   Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.
   Neurology. 2011;77:1998-9.
   PubMed     Text format     Related articles   
   
   
   
   
5. RAMMOHAN KW , Ortega MR, Delgado SR, Tornes L, et al
   Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis.
   Neurology. 2011;77:1930-1.
   PubMed     Text format     Related articles   
   
   
   
   
6. ALBAYRAM S , Kantarci F
   Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS.
   Neurology. 2011;77:e126.
   PubMed     Text format     Related articles   
   
   
   
   
7. BARACCHINI C , Gallo P
   Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS.
   Neurology. 2011;77:e124-5.
   PubMed     Text format     Related articles   
   
   
   
   
8. MOROVIC S , Menegatti E
   Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS.
   Neurology. 2011;77:e124.
   PubMed     Text format     Related articles   
   
   
   
   
9. RIDDELL CA , Zhao Y, Li DK, Petkau AJ, et al
   Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis.
   Neurology. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. BIELEKOVA B , Richert N, Herman ML, Ohayon J, et al
    Intrathecal effects of daclizumab treatment of multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. MARTINELLI V , Cocco E, Capra R, Salemi G, et al
    Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. GIORGIO A , Stromillo ML, Rossi F, Battaglini M, et al
    Cortical lesions in radiologically isolated syndrome.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. ZIVADINOV R , Marr K
    Comment on "Chronic cerebrospinal venous insufficiency: have we found the cause and cure of MS?".
    Neurology. 2011;77:1710.
    PubMed     Text format     Related articles   
    
    
    
    
14. ROVIRA A , Montalban X
    MR brain iron mapping in MS: a potential neurodegenerative marker or just another technique?
    Neurology. 2011;77:1660-1.
    PubMed     Text format     Related articles   
    
    
    
    
15. WOLINSKY JS , Beck CA
    The long march to surrogates of meaningful clinical outcomes in MS trials: are we there yet?
    Neurology. 2011;77:1658-9.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
16. DOEPP F , Wurfel JT, Pfueller CF, Valdueza JM, et al
    Venous drainage in multiple sclerosis: A combined MRI and ultrasound study.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. SOLOMON AJ
    Multiple sclerosis and vitamin D.
    Neurology. 2011;77:e99-e100.
    PubMed     Text format     Related articles   
    
    
    
    
18. STEIN MS , Liu Y, Gray OM, Baker JE, et al
    A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
    Neurology. 2011;77:1611-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. IORIO R , Lucchinetti CF, Lennon VA, Costanzi C, et al
    Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica.
    Neurology. 2011;77:1644-6.
    PubMed     Text format     Related articles   
    
    
    
    
20. BENARROCH EE
    Nitric oxide: A pleiotropic signal in the nervous system.
    Neurology. 2011;77:1568-76.
    PubMed     Text format     Related articles   
    
    
    
    
21. FREEDMAN MS , Bar-Or A, Oger J, Traboulsee A, et al
    A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.
    Neurology. 2011;77:1551-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. PATY DW , Li DK
    Interferon beta-1b is effective in relapsing-remitting multiple-sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Neurology. 2011;77:1431.
    PubMed     Text format     Related articles   
    
    
    
    
23. KHALIL M , Langkammer C, Ropele S, Petrovic K, et al
    Determinants of brain iron in multiple sclerosis: A quantitative 3T MRI study.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. ABBAS M , Lalive PH, Chofflon M, Simon HU, et al
    Hypereosinophilia in patients with multiple sclerosis treated with natalizumab.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. P SORMANI M , Li DK, Bruzzi P, Stubinski B, et al
    Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
26. BARRETO AD
    Time to reevaluate the role of venous hemodynamics in MS pathophysiology?: Controversy mounts.
    Neurology. 2011;77:1218-9.
    PubMed     Text format     Related articles   
    
    
    
    
27. RAO SM , Leo GJ, Haughton VM, St Aubin-Faubert P, et al
    Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis.
    Neurology. 2011;77:1134.
    PubMed     Text format     Related articles   
    
    
    
    
28. MATIELLO M , Schaefer-Klein JL, Hebrink DD, Kingsbury DJ, et al
    Genetic analysis of aquaporin-4 in neuromyelitis optica.
    Neurology. 2011;77:1149-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. SCALFARI A , Neuhaus A, Daumer M, Ebers GC, et al
    Age and disability accumulation in multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. KO MY , Stefoski D, Balabanov R
    Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS.
    Neurology. 2011;77:1020.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
31. HARTUNG HP , Freedman MS, Polman CH, Edan G, et al
    Interferon beta-1b-neutralizing antibodies 5 years after clinically isolated syndrome.
    Neurology. 2011;77:835-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. SIRITHO S , Nakashima I, Takahashi T, Fujihara K, et al
    AQP4 antibody-positive Thai cases: clinical features and diagnostic problems.
    Neurology. 2011;77:827-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. WEINSHENKER BG , Carroll WM
    Does detection of anti-AQP4 antibodies trump clinical criteria for neuromyelitis optica?
    Neurology. 2011;77:812-3.
    PubMed     Text format     Related articles   
    
    
    
    
34. BARACCHINI C , Perini P, Causin F, Calabrese M, et al
    Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. TSIVGOULIS G , Mantatzis M, Bogiatzi C, Vadikolias K, et al
    Extracranial venous hemodynamics in multiple sclerosis: A case-control study.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. COSTANZI C , Matiello M, Lucchinetti CF, Weinshenker BG, et al
    Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica.
    Neurology. 2011;77:659-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. CHAO MJ , Lincoln MR, Dyment DA, Ramagopalan SV, et al
    HLA B*44: Protective effects in MS susceptibility and MRI outcome measures.
    Neurology. 2011;77:602-3.
    PubMed     Text format     Related articles   
    
    
    
    
38. PROBSTEL AK , Dornmair K, Bittner R, Sperl P, et al
    Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
    Neurology. 2011;77:580-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. KANAMORI Y , Nakashima I, Takai Y, Nishiyama S, et al
    Pain in neuromyelitis optica and its effect on quality of life: A cross-sectional study.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
40. COSSBURN M , Pace AA, Jones J, Ali R, et al
    Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. WASCHBISCH A , Sandbrink R, Hartung HP, Kappos L, et al
    Evaluation of soluble HLA-G as a biomarker for multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
42. MINEN MT , Karceski S
    Multiple sclerosis and disease-modifying therapies.
    Neurology. 2011;77:e26.
    PubMed     Text format     Related articles   
    
    
    
    
43. LUCAS RM , Ponsonby AL, Dear K, Valery P, et al
    Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
    Neurology. 2011;77:371-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. SMYTH KA
    Cost-effectiveness analyses of treatments for multiple sclerosis: Are they clinically relevant?
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
45. STOSIC M , De Jesus P, McCarthy J, Hutton G, et al
    Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab.
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
46. NOYES K , Bajorska A, Chappel A, Schwid SR, et al
    Cost-effectiveness of disease-modifying therapy for multiple sclerosis: A population-based study.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. MOEN SM , Celius EG, Sandvik L, Nordsletten L, et al
    Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome.
    Neurology. 2011;77:151-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. BOMPREZZI R , Powers JM, Shimizu J, Tsuji S, et al
    IFNbeta-1b may severely exacerbate Japanese opticspinal MS in neuromyelitis optica spectrum: Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment?
    Neurology. 2011;77:195.
    PubMed     Text format     Related articles   
    
    
    
    
49. NEWEY CR , Bermel RA
    Fulminant cerebral demyelination in neuromyelitis optica.
    Neurology. 2011;77:193.
    PubMed     Text format     Related articles   
    
    
    
    
50. ZIVADINOV R , Marr K, Cutter G, Ramanathan M, et al
    Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS.
    Neurology. 2011;77:138-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. FOX RJ , Rae-Grant A
    Chronic cerebrospinal venous insufficiency: have we found the cause and cure of MS?
    Neurology. 2011;77:98-100.
    PubMed     Text format     Related articles   
    
    
    
    
52. PORTACCIO E , Ghezzi A, Hakiki B, Martinelli V, et al
    Breastfeeding is not related to postpartum relapses in multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
53. FANG L , Isobe N, Yoshimura S, Yonekawa T, et al
    Interleukin-7 receptor alpha gene polymorphism influences multiple sclerosis risk in Asians.
    Neurology. 2011;76:2125-2127.
    PubMed     Text format     Related articles   
    
    
    
    
54. BRENNER SR
    Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency.
    Neurology. 2011;76:2130.
    PubMed     Text format     Related articles   
    
    
    
    
55. HAUPTS MR , Meyer-Schwickerath R, Hacker A, Haug C, et al
    Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency.
    Neurology. 2011;76:2131.
    PubMed     Text format     Related articles   
    
    
    
    
56. SENA A , Pedrosa R, Ferret-Sena V
    Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency.
    Neurology. 2011;76:2130-1.
    PubMed     Text format     Related articles   
    
    
    
    
57. ROCCA MA , Horsfield MA, Sala S, Copetti M, et al
    A multicenter assessment of cervical cord atrophy among MS clinical phenotypes.
    Neurology. 2011;76:2096-102.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. GHOLIPOUR T , Healy B, Baruch NF, Weiner HL, et al
    Demographic and clinical characteristics of malignant multiple sclerosis.
    Neurology. 2011;76:1996-2001.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. WAUBANT E , Mowry EM, Krupp L, Chitnis T, et al
    Common viruses associated with lower pediatric multiple sclerosis risk.
    Neurology. 2011;76:1989-1995.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
60. THOUVENOT E , Schmidt C, Heroum C, Carlander B, et al
    Diabetes insipidus as a first manifestation in multiple sclerosis.
    Neurology. 2011;76:1939-40.
    PubMed     Text format     Related articles   
    
    
    
    
61. RIISE T , Mohr DC, Munger KL, Rich-Edwards JW, et al
    Stress and the risk of multiple sclerosis.
    Neurology. 2011;76:1866-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. CHARD DT , Geurts JJ
    Predicting the development of multiple sclerosis: Is gray matter a missing piece of the puzzle?
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
63. SOMBEKKE MH , Jafari N, Bendfeldt K, Mueller-Lenke N, et al
    No influence of KIF1B on neurodegenerative markers in multiple sclerosis.
    Neurology. 2011;76:1843-5.
    PubMed     Text format     Related articles   
    
    
    
    
64. GELFAND JM , Cree BA, McElroy J, Oksenberg J, et al
    Vitamin D in African Americans with multiple sclerosis.
    Neurology. 2011;76:1824-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. PANITCH HS , Hirsch RL, Schindler J, Johnson KP, et al
    Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system.
    Neurology. 2011;76:1734.
    PubMed     Text format     Related articles   
    
    
    
    
66. POPESCU BF , Bunyan RF, Parisi JE, Ransohoff RM, et al
    A case of multiple sclerosis presenting with inflammatory cortical demyelination.
    Neurology. 2011;76:1705-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. VERMERSCH P , Kappos L, Gold R, Foley JF, et al
    Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy.
    Neurology. 2011;76:1697-704.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. CLIFFORD DB
    Time is brain for infections too?
    Neurology. 2011;76:1688-9.
    PubMed     Text format     Related articles   
    
    
    
    
69. LATERRE EC , Callewaert A, Heremans JF, Sfaello Z, et al
    Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system.
    Neurology. 2011;76:1667.
    PubMed     Text format     Related articles   
    
    
    
    
70. TILIKETE C , Jasse L, Pelisson D, Vukusic S, et al
    Acquired pendular nystagmus in multiple sclerosis and oculopalatal tremor.
    Neurology. 2011;76:1650-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. NAISMITH RT , Bourdette D
    Interruption of natalizumab therapy for multiple sclerosis: What are the risks?
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
72. O'CONNOR PW , Goodman A, Kappos L, Lublin FD, et al
    Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
73. ASGARI N , Lillevang ST, Skejoe HP, Falah M, et al
    A population-based study of neuromyelitis optica in Caucasians.
    Neurology. 2011;76:1589-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
74. NEUTEBOOM RF , Hintzen RQ, Airas L
    Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
    Neurology. 2011;76:1532-3.
    PubMed     Text format     Related articles   
    
    
    
    
75. KRUPP LB , Christodoulou C, Melville P, Scherl WF, et al
    Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.
    Neurology. 2011;76:1500-7.
    PubMed     Text format     Related articles   
    
    
    
    
76. RAMAGOPALAN SV , Handel AE, Giovannoni G, Rutherford Siegel S, et al
    Relationship of UV exposure to prevalence of multiple sclerosis in England.
    Neurology. 2011;76:1410-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. OTTO C , Oltmann A, Stein A, Frenzel K, et al
    Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis.
    Neurology. 2011;76:1316-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. PELLKOFER HL , Krumbholz M, Berthele A, Hemmer B, et al
    Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab.
    Neurology. 2011;76:1310-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. FILIPPI M , Rocca MA, Camesasca F, Cook S, et al
    Interferon beta-1b and glatiramer acetate effects on permanent black hole evolution.
    Neurology. 2011;76:1222-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. KOWARIK MC , Pellkofer HL, Cepok S, Korn T, et al
    Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.
    Neurology. 2011;76:1214-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. POPESCU BF , Lennon VA, Parisi JE, Howe CL, et al
    Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications.
    Neurology. 2011;76:1229-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. GIOVANNONI G , Nath A
    After the storm: neurofilament levels as a surrogate endpoint for neuroaxonal damage.
    Neurology. 2011;76:1200-1.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
83. DELOIRE MS , Ruet A, Hamel D, Bonnet M, et al
    MRI predictors of cognitive outcome in early multiple sclerosis.
    Neurology. 2011;76:1161-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. HONARMAND K , Tierney MC, O'Connor P, Feinstein A, et al
    Effects of cannabis on cognitive function in patients with multiple sclerosis.
    Neurology. 2011;76:1153-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. MCKEON A , Pittock SJ, Lennon VA
    CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG.
    Neurology. 2011;76:1108-10.
    PubMed     Text format     Related articles   
    
    
    
    
86. FASSAS A , Kimiskidis VK, Sakellari I, Kapinas K, et al
    Long-term results of stem cell transplantation for MS: a single-center experience.
    Neurology. 2011;76:1066-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. EBERS GC , Daumer M, Scalfari A, Rudick R, et al
    Surrogate endpoints for EDSS worsening in multiple sclerosis: A meta-analytic approach: Measuring disability in relapsing-remitting MS.
    Neurology. 2011;76:1025-6.
    PubMed     Text format     Related articles   
    
    
    
    
88. UCCELLI A , Ginocchio F, Mancardi GL, Bassetti M, et al
    Primary varicella zoster infection associated with fingolimod treatment.
    Neurology. 2011;76:1023-4.
    PubMed     Text format     Related articles   
    
    
    
    
89. ABSINTA M , Rocca MA, Moiola L, Copetti M, et al
    Cortical lesions in children with multiple sclerosis.
    Neurology. 2011;76:910-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. SOFRONIEW MV
    Neuromyelitis optica: Circulating autoantibodies provoke astrocyte-mediated neural dysfunction.
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
91. BONNET M , Deloire M, Brochet B, Sumowski JF, et al
    Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis.
    Neurology. 2011;76:847-8.
    PubMed     Text format     Related articles   
    
    
    
    
92. DISANTO G , Magalhaes S, Handel AE, Morrison KM, et al
    HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.
    Neurology. 2011;76:781-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
93. KUHLE J , Leppert D, Petzold A, Regeniter A, et al
    Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. HASAN SK , Buttari F, Ottone T, Voso MT, et al
    Risk of acute promyelocytic leukemia in multiple sclerosis: Coding variants of DNA repair genes.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. HOHLFELD R , Barkhof F, Polman C
    Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy.
    Neurology. 2011;76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. MEHLING M , Johnson TA, Antel J, Kappos L, et al
    Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
    Neurology. 2011;76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. PINSCHEWER DD , Brinkmann V, Merkler D
    Impact of sphingosine 1-phosphate modulation on immune outcomes.
    Neurology. 2011;76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. SORENSEN PS , Koch-Henriksen N, Jensen PE
    Neutralizing antibodies against interferon-beta do not predispose antibodies against natalizumab.
    Neurology. 2011;76:759-60.
    PubMed     Text format     Related articles   
    
    
    
    
99. LOITFELDER M , Fazekas F, Petrovic K, Fuchs S, et al
    Reorganization in cognitive networks with progression of multiple sclerosis: Insights from fMRI.
    Neurology. 2011;76:526-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. VENNEGOOR A , Wattjes MP, van Munster ET, Kriekaart RL, et al
     Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS.
     Neurology. 2011;76:574-6.
     PubMed     Text format     Related articles   
     
     
     
     
101. LUCAS RM , Ponsonby AL, Dear K, Valery PC, et al
     Sun exposure and vitamin D are independent risk factors for CNS demyelination.
     Neurology. 2011;76:540-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. TALLANTYRE EC , Dixon JE, Donaldson I, Owens T, et al
     Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions.
     Neurology. 2011;76:534-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. ORTON SM , Wald L, Confavreux C, Vukusic S, et al
     Association of UV radiation with multiple sclerosis prevalence and sex ratio in France.
     Neurology. 2011;76:425-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2011
104. BOURDETTE D , Yadav V
     The radiologically isolated syndrome revisited: When is it presymptomatic multiple sclerosis?
     Neurology. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
105. CORTESE I , Chaudhry V, So YT, Cantor F, et al
     Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
     Neurology. 2011;76:294-300.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. BENARROCH EE
     Na+, K+-ATPase: functions in the nervous system and involvement in neurologic disease.
     Neurology. 2011;76:287-93.
     PubMed     Text format     Related articles   
     
     
     
     
107. CHAO MJ , Ramagopalan SV, Herrera BM, Orton SM, et al
     MHC transmission: insights into gender bias in MS susceptibility.
     Neurology. 2011;76:242-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. KANTARCI OH
     Sex-stratified inheritance of MS: new horizons from studies in MHC region.
     Neurology. 2011;76:210-2.
     PubMed     Text format     Related articles   
     
     
     
     
109. HARRISON DM , Caffo BS, Shiee N, Farrell JA, et al
     Longitudinal changes in diffusion tensor-based quantitative MRI in multiple sclerosis.
     Neurology. 2011;76:179-86.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. GEURTS JJ , Roosendaal SD, Calabrese M, Ciccarelli O, et al
     Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI.
     Neurology. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. CHEN JT , Pirko I
     MS cortical lesion or not?: Double inversion recovery MRI reveals some answers and uncertainties.
     Neurology. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
112. BATES D
     Long-term outcomes in patients with multiple sclerosis. Introduction.
     Neurology. 2011;76.
     PubMed     Text format     Related articles   
     
     
     
     
113. HURWITZ BJ
     Analysis of current multiple sclerosis registries.
     Neurology. 2011;76.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. HURWITZ BJ
     Registry studies of long-term multiple sclerosis outcomes: description of key registries.
     Neurology. 2011;76.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. FREEDMAN MS
     Long-term follow-up of clinical trials of multiple sclerosis therapies.
     Neurology. 2011;76.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. BATES D
     Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.
     Neurology. 2011;76.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. BATES D
     Summary: Registry data.
     Neurology. 2011;76.
     PubMed     Text format     Related articles   
     
     
     
     
118. FREEDMAN MS
     Improving long-term follow-up studies of immunomodulatory therapies.
     Neurology. 2011;76.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2010
119. JERET JS , Suzuki N, Takahashi T, Fujihara K, et al
     Neuromyelitis optica preceded by hyperCKemia episode.
     Neurology. 2010;75:2253 author reply 2253-4.
     PubMed     Text format     Related articles   
     
     
     
     
120. FILIPPI M , Rocca MA, Benedict RH, Deluca J, et al
     The contribution of MRI in assessing cognitive impairment in multiple sclerosis.
     Neurology. 2010;75:2121-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. ROSS KA , Schwebel DC, Rinker J 2nd, Ness J, et al
     Neurocognitive sequelae in African American and Caucasian children with multiple sclerosis.
     Neurology. 2010;75:2097-102.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. POPESCU BF , Parisi JE, Cabrera-Gomez JA, Newell K, et al
     Absence of cortical demyelination in neuromyelitis optica.
     Neurology. 2010;75:2103-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. MARRIE RA
     Cognitive test results in pediatric MS: what do racial disparities tell us?
     Neurology. 2010;75:2054-5.
     PubMed     Text format     Related articles   
     
     
     
     November 2010
124. FILIPPI M , Rocca MA, Calabrese M, Sormani MP, et al
     Intracortical lesions: Relevance for new MRI diagnostic criteria for multiple sclerosis.
     Neurology. 2010;75:1988-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. TINTORE M , Rovira A, Arrambide G, Mitjana R, et al
     Brainstem lesions in clinically isolated syndromes.
     Neurology. 2010;75:1933-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. AMATO MP , Portaccio E, Ghezzi A, Hakiki B, et al
     Pregnancy and fetal outcomes after interferon-{beta} exposure in multiple sclerosis.
     Neurology. 2010;75:1794-1802.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. TANAKA Y , Kimura K, Kawachi I, Inuzuka T, et al
     No relapse of neuromyelitis optica during drug-induced B-lymphopenia with hypogammaglobulinemia.
     Neurology. 2010;75:1745-7.
     PubMed     Text format     Related articles   
     
     
     
     
128. HUPPKE P , Bluthner M, Bauer O, Stark W, et al
     Neuromyelitis optica and NMO-IgG in European pediatric patients.
     Neurology. 2010;75:1740-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. MIRAVALLE A , Corboy JR
     Therapeutic options in multiple sclerosis: Five new things.
     Neurology. 2010;75.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. BENYOUNES N , Gout O
     Fatigue and dizziness during steroid perfusion.
     Neurology. 2010;75:1656-7.
     PubMed     Text format     Related articles   
     
     
     
     
131. WORTHINGTON V , Killestein J, Eikelenboom MJ, Teunissen CE, et al
     Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency.
     Neurology. 2010;75:1617-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     October 2010
132. RISON RA , Berkovich R
     Teaching NeuroImages: hiccoughs and vomiting in neuromyelitis optica.
     Neurology. 2010;75:e70.
     PubMed     Text format     Related articles   
     
     
     
     
133. KIM NH , Kim HJ, Cheong HK, Kim BJ, et al
     Prevalence of multiple sclerosis in Korea.
     Neurology. 2010;75:1432-1438.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. SUMOWSKI JF , Wylie GR, Gonnella A, Chiaravalloti N, et al
     Premorbid cognitive leisure independently contributes to cognitive reserve in multiple sclerosis.
     Neurology. 2010;75:1428-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. SHIMIZU J , Hatanaka Y, Hasegawa M, Iwata A, et al
     IFNbeta-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum.
     Neurology. 2010;75:1423-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. WEINSHENKER BG , Wingerchuk DM
     Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment?
     Neurology. 2010;75:1404-5.
     PubMed     Text format     Related articles   
     
     
     
     
137. ZHANG Y , Metz LM
     Dominant perivenular enhancement of tumefactive demyelinating lesions in multiple sclerosis.
     Neurology. 2010;75:1396.
     PubMed     Text format     Related articles   
     
     
     
     
138. BONNET MC , Allard M, Dilharreguy B, Deloire M, et al
     Cognitive compensation failure in multiple sclerosis.
     Neurology. 2010;75:1241-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. REDER AT
     MxA: A biomarker for predicting multiple sclerosis disease activity.
     Neurology. 2010;75:1222-3.
     PubMed     Text format     Related articles   
     
     
     
     
140. VAN DER VOORT LF , Vennegoor A, Visser A, Knol DL, et al
     Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS.
     Neurology. 2010;75:1228-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
141. VAN RENSBURG SJ , van Toorn R
     The controversy of CCSVI and iron in multiple sclerosis: Is ferritin the key?
     Neurology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
142. TAVEE J , Stone L
     Healing the mind: Meditation and multiple sclerosis.
     Neurology. 2010;75:1130-1.
     PubMed     Text format     Related articles   
     
     
     
     
143. GROSSMAN P , Kappos L, Gensicke H, D'Souza M, et al
     MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial.
     Neurology. 2010;75:1141-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. AMATO MP , Goretti B, Ghezzi A, Lori S, et al
     Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up.
     Neurology. 2010;75:1134-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. KRUPP LB , Benedict RH
     Down a slippery slope: cognitive changes in pediatric MS.
     Neurology. 2010;75:1128-9.
     PubMed     Text format     Related articles   
     
     
     
     
146. COLLONGUES N , Marignier R, Zephir H, Papeix C, et al
     Long-term follow-up of neuromyelitis optica with a pediatric onset.
     Neurology. 2010;75:1084-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. GHEZZI A , Pozzilli C, Grimaldi LM, Brescia Morra V, et al
     Safety and efficacy of natalizumab in children with multiple sclerosis.
     Neurology. 2010;75:912-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
148. INGRAM G , Hirst CL, Robertson NP, Rolak LA, et al
     What is the risk of permanent disability from a multiple sclerosis relapse?
     Neurology. 2010;75:837-8.
     PubMed     Text format     Related articles   
     
     
     
     
149. CROSS AH , Parks BJ
     The four seasons of multiple sclerosis.
     Neurology. 2010;75:762-3.
     PubMed     Text format     Related articles   
     
     
     
     
150. LENHARD T , Biller A, Mueller W, Metz I, et al
     Immune reconstitution inflammatory syndrome after withdrawal of natalizumab?
     Neurology. 2010;75:831-3.
     PubMed     Text format     Related articles   
     
     
     
     
151. MEIER DS , Balashov KE, Healy B, Weiner HL, et al
     Seasonal prevalence of MS disease activity.
     Neurology. 2010;75:799-806.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
152. CALABRESE M , Battaglini M, Giorgio A, Atzori M, et al
     Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. GEURTS JJ , Vrenken H
     Toward understanding cortical lesions in multiple sclerosis.
     Neurology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
154. EXLEY C
     Combined effects of smoking, anti-ebna antibodies, and hla-drb1*1501 on multiple sclerosis risk.
     Neurology. 2010;75:752.
     PubMed     Text format     Related articles   
     
     
     
     
155. HEALY BC , Liguori M, Tran D, Chitnis T, et al
     HLA B*44: Protective effects in MS susceptibility and MRI outcome measures.
     Neurology. 2010;75:634-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
156. AIRAS L , Jalkanen A, Alanen A, Pirttila T, et al
     Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
     Neurology. 2010;75:474-6.
     PubMed     Text format     Related articles   
     
     
     
     
157. O'BRIEN M , Lonergan R, Costelloe L, O'Rourke K, et al
     OAS1: A multiple sclerosis susceptibility gene that influences disease severity.
     Neurology. 2010;75:411-418.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
158. KIESEIER BC , Wiendl H
     Postpartum disease activity and breastfeeding in multiple sclerosis revisited.
     Neurology. 2010;75:392-3.
     PubMed     Text format     Related articles   
     
     
     
     
159. SLAVIN AJ , Zamvil SS
     FTY720 and central memory: out of sight, out of mind.
     Neurology. 2010;75:388-9.
     PubMed     Text format     Related articles   
     
     
     
     July 2010
160. MATIELLO M , Kim HJ, Kim W, Brum DG, et al
     Familial neuromyelitis optica.
     Neurology. 2010;75:310-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. RUDICK RA , Kappos L
     Measuring disability in relapsing-remitting MS.
     Neurology. 2010;75:296-7.
     PubMed     Text format     Related articles   
     
     
     
     
162. KISTER I , Chamot E, Bacon JH, Niewczyk PM, et al
     Rapid disease course in African Americans with multiple sclerosis.
     Neurology. 2010;75:217-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
163. TAKANO R , Misu T, Takahashi T, Sato S, et al
     Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
     Neurology. 2010;75:208-16.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
164. ARMSTRONG RJ , Elston JS, Hatton CS, Ebers GC, et al
     De novo relapsing-remitting multiple sclerosis following autologous stem cell transplantation.
     Neurology. 2010;75:89-91.
     PubMed     Text format     Related articles   
     
     
     
     June 2010
165. MEHLING M , Lindberg R, Raulf F, Kuhle J, et al
     Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
166. SORMANI MP , Bonzano L, Roccatagliata L, Mancardi GL, et al
     Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
167. SCHWARZ A , Korporal M, Hosch W, Max R, et al
     Critical vasospasm during Fingolimod (FTY720) treatment in a patient with multiple sclerosis.
     Neurology. 2010;74:2022-4.
     PubMed     Text format     Related articles   
     
     
     
     
168. TREMLETT H , Zhao Y, Rieckmann P, Hutchinson M, et al
     New perspectives in the natural history of multiple sclerosis.
     Neurology. 2010;74:2004-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
169. SUMOWSKI JF , Wylie GR, Chiaravalloti N, DeLuca J, et al
     Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis.
     Neurology. 2010;74:1942-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
170. ARNETT PA
     Does cognitive reserve apply to multiple sclerosis?
     Neurology. 2010;74:1934-5.
     PubMed     Text format     Related articles   
     
     
     
     
171. HANDUNNETTHI L , Ramagopalan SV, Ebers GC
     Multiple sclerosis, vitamin D, and HLA-DRB1*15.
     Neurology. 2010;74:1905-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
172. DE STEFANO N , Giorgio A, Battaglini M, Rovaris M, et al
     Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes.
     Neurology. 2010;74:1868-76.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
173. NAISMITH RT , Piccio L, Lyons JA, Lauber J, et al
     Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial.
     Neurology. 2010;74:1860-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
174. REDER AT , Ebers GC, Traboulsee A, Li D, et al
     Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
     Neurology. 2010;74:1877-85.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
175. KINGWELL E , Koch M, Leung B, Isserow S, et al
     Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.
     Neurology. 2010;74:1822-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
176. NAISMITH RT , Xu J, Tutlam NT, Scully PT, et al
     Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole.
     Neurology. 2010;74:1694-701.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
177. GOETZ CG
     Shaking up the Salpetriere: Jean-Martin Charcot and mercury-induced tremor.
     Neurology. 2010;74:1739-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
178. GHAFFAR O , Reis M, Pennell N, O'Connor P, et al
     APOE epsilon4 and the cognitive genetics of multiple sclerosis.
     Neurology. 2010;74:1611-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
179. BUGNICOURT JM , Garcia PY, Monet P, Bonnaire B, et al
     Teaching NeuroImages: Marked reduced apparent diffusion coefficient in acute multiple sclerosis lesion.
     Neurology. 2010;74:e87.
     PubMed     Text format     Related articles   
     
     
     
     
180. ZHANG H , Wu J
     A cross-sectional study of bone health in multiple sclerosis.
     Neurology. 2010;74:1554.
     PubMed     Text format     Related articles   
     
     
     
     
181. SUZUKI N , Takahashi T, Aoki M, Misu T, et al
     Neuromyelitis optica preceded by hyperCKemia episode.
     Neurology. 2010;74:1543-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
182. WINGERCHUK DM
     Supplementing our understanding of vitamin D and multiple sclerosis.
     Neurology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
183. MARRIOTT JJ , Miyasaki JM, Gronseth G, O'Connor PW, et al
     Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
     Neurology. 2010;74:1463-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
184. BOURDETTE D , Whitham R
     Immunotherapy and multiple sclerosis: The devil is in the details.
     Neurology. 2010;74:1410-1.
     PubMed     Text format     Related articles   
     
     
     
     
185. MATIELLO M , Magana SM, Weinshenker BG
     Asymptomatic spinal cord involvement in posterior reversible encephalopathy syndrome.
     Neurology. 2010;74:1478-9.
     PubMed     Text format     Related articles   
     
     
     
     
186. KRUER MC , Koch TK, Bourdette DN, Chabas D, et al
     NMDA receptor encephalitis mimicking seronegative neuromyelitis optica.
     Neurology. 2010;74:1473-5.
     PubMed     Text format     Related articles   
     
     
     
     
187. SANCHEZ-CARTEYRON A , Alarcia R, Ara JR, Martin J, et al
     Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica.
     Neurology. 2010;74:1471-3.
     PubMed     Text format     Related articles   
     
     
     
     
188. HESSE D , Krakauer M, Lund H, Sondergaard HB, et al
     Breakthrough disease during interferon-[beta] therapy in MS: No signs of impaired biologic response.
     Neurology. 2010;74:1455-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2010
189. BURTON JM , Kimball S, Vieth R, Bar-Or A, et al
     A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
190. POLMAN CH , Rudick RA
     The multiple sclerosis functional composite: a clinically meaningful measure of disability.
     Neurology. 2010;74 Suppl 3:S8-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
191. HAVRDOVA E , Galetta S, Stefoski D, Comi G, et al
     Freedom from disease activity in multiple sclerosis.
     Neurology. 2010;74 Suppl 3:S3-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
192. BALCER LJ , Frohman EM
     Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity.
     Neurology. 2010;74 Suppl 3:S16-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
193. COHEN M , Rocher F, Vivinus S, Thomas P, et al
     Giant urticaria and persistent neutralizing antibodies after the first natalizumab infusion.
     Neurology. 2010;74:1394-5.
     PubMed     Text format     Related articles   
     
     
     
     
194. MILLER D , Rudick RA, Hutchinson M
     Patient-centered outcomes: translating clinical efficacy into benefits on health-related quality of life.
     Neurology. 2010;74 Suppl 3:S24-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
195. SCHOONHEIM MM , Geurts JJ, Barkhof F
     The limits of functional reorganization in multiple sclerosis.
     Neurology. 2010;74:1246-7.
     PubMed     Text format     Related articles   
     
     
     
     
196. ROCCA MA , Valsasina P, Absinta M, Riccitelli G, et al
     Default-mode network dysfunction and cognitive impairment in progressive MS.
     Neurology. 2010;74:1252-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
197. SIMON KC , van der Mei IA, Munger KL, Ponsonby A, et al
     Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
198. TERRACCIANO A , Foulds NC, Ditchfield A, Bunyan DJ, et al
     Pseudodominant inheritance of spastic ataxia of Charlevoix-Saguenay.
     Neurology. 2010;74:1152-4.
     PubMed     Text format     Related articles   
     
     
     
     
199. ASCHERIO A , Bar-Or A
     EBV and brain matter(s)?
     Neurology. 2010;74:1092-5.
     PubMed     Text format     Related articles   
     
     
     
     March 2010
200. YEH EA , Tardieu M
     How well can MRI predict MS in children with acute disseminated encephalomyelitis?
     Neurology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
201. MARRIE RA , Rudick R, Horwitz R, Cutter G, et al
     Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.
     Neurology. 2010;74:1041-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
202. KETELSLEGERS IA , Neuteboom RF, Boon M, Catsman-Berrevoets CE, et al
     A comparison of MRI criteria for diagnosing pediatric ADEM and MS.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
203. KILLESTEIN J , van der Meer ML, Regelink JC, Huijgens PC, et al
     Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment.
     Neurology. 2010;74:934.
     PubMed     Text format     Related articles   
     
     
     
     
204. BEJAOUI K , Rolak LA
     What is the risk of permanent disability from a multiple sclerosis relapse?
     Neurology. 2010;74:900-2.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
205. FLEMING JO , Carrithers MD
     Diagnosis and management of multiple sclerosis: A handful of patience.
     Neurology. 2010;74:876-7.
     PubMed     Text format     Related articles   
     
     
     
     
206. SARGSYAN SA , Shearer AJ, Ritchie AM, Burgoon MP, et al
     Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
207. RIVERA VM
     The challenge of follow-on biologics for treatment of multiple sclerosis.
     Neurology. 2010;74:864.
     PubMed     Text format     Related articles   
     
     
     
     
208. DAVIS M , Auh S, Riva M, Richert ND, et al
     Ring and nodular multiple sclerosis lesions: A retrospective natural history study.
     Neurology. 2010;74:851-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
209. SUTEDJA NA , Otten HG, Cats EA, Piepers S, et al
     Increased frequency of HLA-DRB1*15 in patients with multifocal motor neuropathy.
     Neurology. 2010;74:828-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
210. FOX RJ
     Primary neuroprotection. The Holy Grail of multiple sclerosis therapy.
     Neurology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
211. BARKHOF F , Hulst HE, Drulovic J, Uitdehaag BM, et al
     Ibudilast in relapsing-remitting multiple sclerosis. A neuroprotectant?
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
212. ZELLER D , Aufm Kampe K, Biller A, Stefan K, et al
     Rapid-onset central motor plasticity in multiple sclerosis.
     Neurology. 2010;74:728-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
213. COLLONGUES N , Marignier R, Zephir H, Papeix C, et al
     Neuromyelitis optica in France: a multicenter study of 125 patients.
     Neurology. 2010;74:736-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
214. GEURTS JJ , van Horssen J
     The brake on neurodegeneration: Increased mitochondrial metabolism in the injured MS spinal cord.
     Neurology. 2010;74:710-1.
     PubMed     Text format     Related articles   
     
     
     
     
215. CICCARELLI O , Altmann DR, McLean MA, Wheeler-Kingshott CA, et al
     Spinal cord repair in MS: does mitochondrial metabolism play a role?
     Neurology. 2010;74:721-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2010
216. JOHNSON KP , Fox RJ, Arnold DL
     Seeing injectable ms therapies differently: they are more similar than different.
     Neurology. 2010;74:702.
     PubMed     Text format     Related articles   
     
     
     
     
217. HOFER S , Linnebank M, Weller M, Bahmanyar S, et al
     Cancer risk among patients with multiple sclerosis and their parents.
     Neurology. 2010;74:614-5.
     PubMed     Text format     Related articles   
     
     
     
     
218. PENNY S , Khaleeli Z, Cipolotti L, Thompson A, et al
     Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis.
     Neurology. 2010;74:545-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
219. BENARROCH EE
     Adenosine triphosphate: a multifaceted chemical signal in the nervous system.
     Neurology. 2010;74:601-7.
     PubMed     Text format     Related articles   
     
     
     
     
220. GUTWINSKI S , Erbe S, Munch C, Janke O, et al
     Severe cutaneous Candida infection during natalizumab therapy in multiple sclerosis.
     Neurology. 2010;74:521-3.
     PubMed     Text format     Related articles   
     
     
     
     
221. CHABAS D , Ness J, Belman A, Yeh EA, et al
     Younger children with MS have a distinct CSF inflammatory profile at disease onset.
     Neurology. 2010;74:399-405.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2010
222. CALABRESE M , Rinaldi F, Mattisi I, Grossi P, et al
     Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
     Neurology. 2010;74:321-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
223. WEINSTOCK-GUTTMAN B , Ramanathan M, Hashmi K, Abdelrahman N, et al
     Increased tissue damage and lesion volumes in African Americans with multiple sclerosis.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
224. CREE B , Waubant E
     Does race matter for multiple sclerosis?
     Neurology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
225. MARRIE RA , Yu N, Blanchard J, Leung S, et al
     The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
226. ROCCA MA , Ceccarelli A, Rodegher M, Misci P, et al
     Preserved brain adaptive properties in patients with benign multiple sclerosis.
     Neurology. 2010;74:142-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
227. OKADA K , Matsushita T, Kira J, Tsuji S, et al
     B-cell activating factor of the TNF family is upregulated in neuromyelitis optica.
     Neurology. 2010;74:177-8.
     PubMed     Text format     Related articles   
     
     
     
     
228. MONTALBAN X , Tintore M, Swanton J, Barkhof F, et al
     MRI criteria for MS in patients with clinically isolated syndromes.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
229. PAPPAS DJ , Oksenberg JR
     Multiple sclerosis pharmacogenomics: maximizing efficacy of therapy.
     Neurology. 2010;74 Suppl 1:S62-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
230. LEIST TP , Marks S
     Magnetic resonance imaging and treatment effects of multiple sclerosis therapeutics.
     Neurology. 2010;74 Suppl 1:S54-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
231. RAMMOHAN KW , Shoemaker J
     Emerging multiple sclerosis oral therapies.
     Neurology. 2010;74 Suppl 1:S47-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
232. RACKE MK , Lovett-Racke AE, Karandikar NJ
     The mechanism of action of glatiramer acetate treatment in multiple sclerosis.
     Neurology. 2010;74 Suppl 1:S25-30.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
233. KASPER LH , Shoemaker J
     Multiple sclerosis immunology: The healthy immune system vs the MS immune system.
     Neurology. 2010;74 Suppl 1:S2-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
234. DHIB-JALBUT S , Marks S
     Interferon-beta mechanisms of action in multiple sclerosis.
     Neurology. 2010;74 Suppl 1:S17-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
235. LISAK RP , Korngold S
     Insights for practice: where mechanism of action meets patient management.
     Neurology. 2010;74 Suppl 1:S70-3.
     PubMed     Text format     Related articles   
     
     
     
     
236. VOLLMER T , Stewart T, Baxter N
     Mitoxantrone and cytotoxic drugs' mechanisms of action.
     Neurology. 2010;74 Suppl 1:S41-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
237. BIELEKOVA B , Becker BL
     Monoclonal antibodies in MS: mechanisms of action.
     Neurology. 2010;74 Suppl 1:S31-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: